Your browser doesn't support javascript.
loading
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers.
Kurose, Koji; Sakaeda, Kanako; Fukuda, Minoru; Sakai, Yumiko; Yamaguchi, Hiroyuki; Takemoto, Shinnosuke; Shimizu, Katsuhiko; Masuda, Takeshi; Nakatomi, Katsumi; Kawase, Shigeo; Tanaka, Ryo; Suetsugu, Takayuki; Mizuno, Keiko; Hasegawa, Takehiro; Atarashi, Yusuke; Irino, Yasuhiro; Sato, Toshiyuki; Inoue, Hiromasa; Hattori, Noboru; Kanda, Eiichiro; Nakata, Masao; Mukae, Hiroshi; Oga, Toru; Oka, Mikio.
Afiliación
  • Kurose K; Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan.
  • Sakaeda K; Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Fukuda M; Cancer Treatment Center, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan.
  • Sakai Y; Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Yamaguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Takemoto S; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Shimizu K; General Thoracic Surgery, Kawasaki Medical School, Okayama, Japan.
  • Masuda T; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
  • Nakatomi K; Department of Respiratory Medicine, NHO Ureshino Medical Center, Saga, Japan.
  • Kawase S; Department of Respiratory Medicine, Kure Kyosai Hospital, Hiroshima, Japan.
  • Tanaka R; Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
  • Suetsugu T; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Mizuno K; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Hasegawa T; Sysmex R&D Centre Europe GmbH, Hamburg, Germany.
  • Atarashi Y; Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Irino Y; Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Sato T; Central Research Laboratories, Sysmex Corporation, Hyogo, Japan.
  • Inoue H; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Hattori N; Department of Molecular and Internal Medicine, Graduate School of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Kanda E; Department of Medical Science, Kawasaki Medical School, Okayama, Japan.
  • Nakata M; General Thoracic Surgery, Kawasaki Medical School, Okayama, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Oga T; Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan.
  • Oka M; Department of Immuno-Oncology, Kawasaki Medical School, Okayama, Japan. Electronic address: moom@med.kawasaki-m.ac.jp.
Adv Clin Chem ; 112: 155-204, 2023.
Article en En | MEDLINE | ID: mdl-36642483

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Adv Clin Chem Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Adv Clin Chem Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos